Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Montefiore Medical Center
4th Floor, Clinic 4603444 Kossuth Avenue
Bronx, New York, United States
Phone Web
At the Division of Hematology at Montefiore Medical Center, our internationally recognized hematologists and multidisciplinary experts offer the highest quality care for the management of a broad spectrum of blood disorders, including:
-Anemias, acquired or hereditary hemoglobinopathies, thalassemias
-White cell disorders, such as leukopenia and leukocytosis
-Stem cell disorders
-Platelet disorders
-Thrombosis or a blood clot in an artery
-Hemorrhagic or bleeding disorders
-Chronic leukemias, including chronic myeloid and lymphocytic leukemias
Each year, approximately 6,500 patients come to us from across the United States for consultations, advanced diagnostics and treatments, and specialty care. Our team of physicians has expertise in the diagnosis and treatment of thrombosis and in sickle-cell anemia and offers coordinated services tailored specifically for patients with these disorders. Physicians, nurse practitioners, a social worker and patient advocate follow our patients in the outpatient clinic, in the Emergency Department, and on inpatient units. The Montefiore Sickle Cell Center for Adults (SCCA) Team manages the medical and social service needs of sickle cell patients.
+myBinderRelated Content
-
Patrick Woster, PhDPatrick M. Woster is professor of drug d...
-
Pat Corley, RNPat Corley is a retired nurse coordinato...
-
2019 WEPSCF Rockin’ the Red – 14th Annual FundraiserJoin us as we celebrate National Sickle ...
-
Improving Sickle Cell Transitions of Care Through Health Information TechnologyINTRODUCTION: Transitions between inpati...
-
Opioid Abuse Backlash Could Hurt Sickle Cell Patients’ Medication Needs, Some FearWith drug overdoses now the leading caus...
-
Practice variation in emergency department management of children with sickle cell disease who present with feverOBJECTIVES:Urgent medical evaluation is ...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
